Our cutting-edge cell line development services offer innovative solutions to accelerate your biopharmaceutical research and production. We provide two key offerings.

1. Rapid Bulk Pool Cell Line Establishment

Our EncoreSTAR Technology revolutionizes the cell line development process:

• Enriches high-producing clones prior to single-cell cloning.
• Improves screening efficiency by 10-20 fold.
• Dramatically reduces time and resources required for clone selection.

2. CLD Platform Licensing

License our advanced Cell Line Development (CLD) platform, featuring:

High-Yield Production

• Achieve molecule-dependent titers
• Most monoclonal antibodies reach 5-10 g/L.

Rapid Turnaround

• Streamlined process delivers DNA bulk pools in ~2 weeks.
• Top clones available in ~10 weeks.

EncorePOOL Technology

• Generate stable bulk pools producing 1-5 g/L for most mAbs in just 2 weeks.
• Ideal for early developability assessment and material generation.

EncoreSTAR Technology

• Proprietary method enriches high-producing clones before single-cell cloning.
• Enhances screening efficiency by 10-20 fold.

EncoreSELECT Technology

• Directed evolution approach selects for clones with high productivity and desired phenotypes.
• Improves growth characteristics and product quality attributes.

Find out more information about AmeriDx CLD platform here. By leveraging our advanced technologies and expertise, we help you accelerate your cell line development process, reduce costs, and improve the quality of your biopharmaceutical products.

If interested, please contact us for a discussion.